Express Scripts' pandemic lessons To view this email as a web page,
click here | Webinar: New Trends in Virtual Trials Monday, July 26 | 11am ET / 8am PT Last year, clinical trial platform developer Medable raised $91M in private funding, amid the COVID-19 pandemic that touched off huge demand among pharma companies looking to initiate “siteless” or virtual clinical trials. Explore the role of CROs in siteless trials and the opportunities and challenges for CROs to expand their capabilities in this burgeoning area. Register now. | Quidel recalls a year’s worth of COVID-19 PCR tests over ‘significant risk’ of false negatives U.S. vaccine rollout prevented up to 1.25M hospitalizations, 279K additional deaths, study finds Express Scripts' supply chain lessons learned from COVID-19 New insights into how stem cells shield against RNA viruses could boost COVID-19 R&D COVID-19 tracker: Single Pfizer, AZ shot may not be enough against Delta; Exscientia bags $1.5M for AI-discovered drugs Britain bets on biotech as billions set to boost life sciences sector Featured Story By Andrea Park The recall covers more than three dozen lots of the test, spanning 18,385 kits, each of which can be used to perform 96 analyses. The affected kits were manufactured between March 2020 and March 2021 and were distributed between mid-March 2020 and the end of May this year. read more |
| |
---|
| | Webinar: COVID-19 Virus Sequencing for Drug Development Wednesday, July 28 | 10:30am ET / 7:30am PT As new COVID-19 variants continue to emerge, virus sequencing will play critical and ongoing role in drug and vaccine development. This webinar will connect insights from population surveillance to potential solutions for drug developers, outline approaches to COVID-19 virus sequencing and more. Register Now. | Top Stories By Robert King A new study found that the U.S. vaccination campaign prevented up to 1.25 million hospitalizations and 279,000 additional deaths. read more By Paige Minemyer As Cigna's Evernoth expands the capabilities under its umbrella, the company is finding new solutions to address waste in the healthcare system. read more By Kyle LaHucik Researchers at the Francis Crick Institute found that stem cells contain instructions to build a protein called antiviral Dicer, which protects them against SARS-CoV-2 and Zika viruses. They believe their insights could inform efforts to develop new therapies for COVID-19 and other infectious diseases. read more By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner The Delta variant "barely" reacted to a single shot of either Pfizer or AstraZeneca's jab, a new study shows. U.K.-based Exscientia scored $1.5 million to use its artificial intelligence to discover a new class of COVID-19 drugs. And more headlines. read more By Ben Adams As the U.K. looks to boost the economy after a major COVID hit—and the looming spotlight of Brexit—the government is creating a new £1 billion public-private partnership in life sciences. British Patient Capital, the commercial arm of the U.K. government’s British Business Bank, is kickstarting the program, funneling £200 million to “specialist funds” designed to “unlock the potential of innovative U.K. life sciences companies so that they can grow their operations and create high-skilled jobs in the U.K.,” according to the government. read more | |